CHICAGO -- Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own ...
Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two companies announced Nov. 3. The companies in news releases billed the ...
Kimberly-Clark (NasdaqGS:KMB) is undergoing what management describes as its largest transformation in 150 years. Capital spending tied to this overhaul led the company to pay more in dividends than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results